Ahaded A, Debbia M, Beolet M, Le Pennec P Y, Lambin P
Unité d'Immunologie Transfusionnelle and the Centre National de Référence des Groupes Sanguins, Institut National de la Transfusion Sanguine, Paris, France.
Transfusion. 1999 May;39(5):515-21. doi: 10.1046/j.1537-2995.1999.39050515.x.
Anti-D immunoglobulin preparations are injected to prevent hemolytic disease of the newborn. The concentration of IgG anti-D in these preparations is usually determined by an automated hemagglutination technique using as a reference a calibrated preparation of anti-D, but the method requires special equipment and cannot be routinely applied to measure the IgG subclasses of anti-D in these preparations.
Taking advantage of a recently described enzyme-linked immunosorbent assay (ELISA) for the determination of the anti-D concentration in sera of alloimmunized pregnant women, IgG anti-D and IgG subclass concentrations were measured in the international reference preparation (IRP) coded 68/419, 10 anti-D immunoglobulin preparations, and sera of 15 D-immunized volunteers.
An IgG anti-D concentration of 61.5 +/- 4.8 microg per ampoule (mean +/- SD) was found by ELISA in IRP 68/419. This result was in agreement with previous determinations obtained by radioimmunoassay (60 microg/ampoule). The IgG subclass concentration of anti-D in this preparation was 48.4 microg of IgG1 (78.6%), 3.0 microg of IgG2 (4.8%), 9.7 microg of IgG3 (15.8%), and 0.4 microg of IgG4 (0.7%). The mean proportion of IgG subclasses of anti-D in 10 immunoglobulin preparations was similar (81.7% for IgG1, 5.0% for IgG2, 12.7% for IgG3, and 0.6% for IgG4). In the sera of 15 immunized volunteers, the IgG anti-D concentration varied from 3.1 to 68.4 microg per mL. The mean IgG subclass composition of anti-D was 79.3 percent for IgG1, 2.2 percent for IgG2, 18.1 percent for IgG3, and 0.4 percent for IgG4. The proportions of IgG3 anti-D in these sera were found to range between 1 percent and 87 percent, as in the sera of D-alloimmunized pregnant women.
ELISA provides an alternative to the radioimmunoassay and the automated hemagglutination technique. In addition, it allows the evaluation of the absolute concentration of each IgG subclass of anti-D in immunoglobulin preparations and necessitates only the conventional equipment required for an immunoenzymatic assay.
注射抗-D免疫球蛋白制剂可预防新生儿溶血病。这些制剂中IgG抗-D的浓度通常采用自动血凝技术测定,以校准的抗-D制剂作为参考,但该方法需要特殊设备,且不能常规用于测定这些制剂中抗-D的IgG亚类。
利用最近描述的酶联免疫吸附测定法(ELISA)测定同种免疫孕妇血清中的抗-D浓度,对编码为68/419的国际参考制剂、10种抗-D免疫球蛋白制剂以及15名D免疫志愿者的血清进行了IgG抗-D和IgG亚类浓度的测定。
通过ELISA法在国际参考制剂68/419中测得的IgG抗-D浓度为每安瓿61.5±4.8微克(平均值±标准差)。该结果与先前通过放射免疫测定法获得的结果(60微克/安瓿)一致。该制剂中抗-D的IgG亚类浓度为IgG1 48.4微克(78.6%)、IgG2 3.0微克(4.8%)、IgG3 9.7微克(15.8%)和IgG4 0.4微克(0.7%)。10种免疫球蛋白制剂中抗-D的IgG亚类平均比例相似(IgG1为81.7%、IgG2为5.0%、IgG3为12.7%、IgG4为0.6%)。在15名免疫志愿者的血清中,IgG抗-D浓度在每毫升3.1至68.4微克之间。抗-D的IgG亚类平均组成比例为IgG1 79.3%、IgG2 2.2%、IgG3 18.1%、IgG4 0.4%。在这些血清中发现IgG3抗-D的比例在1%至87%之间,与D同种免疫孕妇的血清情况相同。
ELISA为放射免疫测定法和自动血凝技术提供了一种替代方法。此外,它还能评估免疫球蛋白制剂中抗-D各IgG亚类的绝对浓度,且仅需免疫酶测定所需的常规设备。